6-K: U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Apr 19 06:15 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 15 06:33 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 27 06:38 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 9 06:09 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 1 06:21 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 16 00:00 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 13, 2023 06:05 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oct 26, 2023 06:22 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oct 18, 2023 06:21 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oct 18, 2023 06:20 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oct 2, 2023 06:17 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sep 28, 2023 06:17 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sep 11, 2023 06:50 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jul 3, 2023 06:02 ET
TAKEDA PHARMACEUTICAL CO LTD | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jun 28, 2023 06:35 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jun 28, 2023 06:02 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jun 23, 2023 06:10 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jun 9, 2023 06:03 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jun 1, 2023 06:02 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
May 30, 2023 06:19 ET
No Data
No Data